SMS Pharmaceuticals Ltd — Interim / Quarterly Report 2021

Aug 17, 2020

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills. Hyderabad - 500 034, Telangana, INDIA. Tel: +91-40-2525 9999, Fax : +91-40-2525 9889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

Date: 17th August, 2020

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towe rs, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Security Code: 532815

Dear Sir/Madam,

Symbol: SMSPHARMA

Sub: Publishing of Financial Results in Newspaper Ref: Regulation 47(1)(b) of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015

Further to our intimation dated August, 1ih, 2020, please find the enclosed herewith copies of the newspaper advertisements published on 14th August, 2020, regarding financial resu lts for quarter ended as on 30th June, 2020. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015

Kindly take the above information on record

Thanking you Yours faithfully,

For SMS Pharmaceuticals Limited

v S Venkatish Compa ny Secretary

Andhora Prabla (Augb-2020)

SMS PHARMACEUTICALS LIMITED

CIN: L24239TG1987PLC008066 Regd. office. Plot No. 72. H.No: 8-2-334/3&4, Road No. 5. Opp. SBI Executive Enclave, Banjara Hills, Hyderabad TG 500034 India Website:www.smspharma.com Email: cs@smspharma.com / complianceofficer@smspharma.com

30 జాన్, 2020తో ముగిసిన త్రైమాసికం కొరకు පවුම කිවසාව ගියාම, බාහාර ගිර

	( egel

ZudioSidipero	බාංඩි පණීබි			ಕನ್ಯಾರಿಡೆವಿದಿ
	ముగ్గీసీనමුතිශබණි	ທ່ານດີວ່າວමුනානමං	butchestsමුණාකිජිං	Zion Backමුකාවෙන්ග	ötdődzákමුණාකමර	doch critsමුනිෂාර්ෂිය
නිජුක්ෂනා නායයී ධිගල්ප සකයෝය (නිමරය)	11,370.73				9,955,45	11,778.85
බන්දුජාකාරයා නිකෙරස කරුමනාධාන නිරේ නාග්ර		863.04	1,534.11		863.04	1,534.11
పన్ను తరువాత బాధారణ కార్యకలాపాల నుండి లాభం(entrope oods sobrastic)			948.11	702.71	639.26	776.78
ಮొత్తం సమగ్ర అదాయం త్రైమాసికం కారకు (లాభం / (సష్టం)తైమాసికం కొరకు (పన్ను తర్వాత) మలియు ఇతర సమగ్రනබිංහා පිවිෆි c ගොඩුවා		623.14	946.00	701.01	632.18	775.06
உருபூதி)		846.52	846.52	846.52	846.52	846.52
లజర్వులు (బ్యాలెన్స్ షేట్ ప్రజారం లీవాల్యుయేషన్ లిజర్నులుమినపశి) - రూ. 1/- ఓక్నొక్కరీ
බුම කාණ පරක්නා (පතිඥාජය කඩාංපති නියාපයිා) -(බවව.ජි ය මාඩ්ඩ්)
a) විබර් / සිහානුගියි (රාං.පජි 6 )				0.83	0.76	0.92
		daded men threedtho (men thum next dr.1/-	1,381.06920.38918.24846.521.09	624.740.74	1.12	30.06.2020 31.03.2020 30.06.2019 30.06.2020 31.03.2020 30.06.20199,955.45 11,778.85 11,370.731,381.06

$\epsilon$ ms

1. పైన తెలిపిన స్పాండ్ అలోన్ మలయు కన్యాలెడేటెడ్ అల్లక ఫలితాలు ఆడిటి కమిటీచే సమీక్షించబడినవి మలయు సిఫార్కు చేయబడినవి మలయు 12 පැති: 2020 නි සවර්නි නාව නිකාමීමිරවේ සිටිපුවූ කිරීලා කාව මි මහානර මායිනිනි කාවරයා පිරකිහි ඒයාම, නිරඹාවම සම්බවම් නවකාණ సమీక చేపట్టలడినవి.

• 1. ఈ ఫరితాలు కంపెనీల చట్టం 2013 యొక్క పెక్షన్ 133 మరియు ఇతర గుర్తించివ గణాంక విధానాలు మరియు వర్తించే పాలసీల క్రింద හරි මරයාගි මරයිනිදා (සුරයිරැවයි මෙමරසීරේ නිරෝධිය) ජාවේ 2015 (සුරයි යන්ඩි) මහිරවරයා මහානිසයිනිය.
• 1. SEBI (ఎల్&డిఆర్) రెగ్నులేషన్స్, 2015 యొక్క రెగ్యులేషన్ 33 క్రింద స్టాక్ ఎక్స్టేంజిలతో దాఖలు చేయబడిన తైనూసిక / వాల్నక అర్ధిక ఫలితాల හත්සෙණුම ත්තාංශා රැගම, හිතාංග බුහි කලිනයින්න. මුකාංගිම / කාදැම පවුම ඉඩගෙ රැගම, කුලෙ ත්තාංශා කුම් යම් යන් කර්බුන් කංතික (www.bseindia.com) (ID 532815) විසං යබ්යබිතු (www.nseindia.com) කාමයා ජරමාර් බන්බුස් (www.SMSPHARMA.com) b codenators and a.

By order of the Board for SMS PHARMACEUTICALS LIMITED RAMESH BABU POTLURI (DIN:00166381) Chairman and Managing Director

Financial Espressor

$\frac{1}{2}$

CIN: L24239TG1987PLC008066 Regd. office. Plot No. 72, H.No: 8-2-334/3&4. Road No. 5. Opp. SBI Executive Enclave, Banjara Hills, Hyderabad TG 500034 India Website:www.smspharma.com Email: cs@smspharma.com / complianceofficer@smspharma.com

EXTRACT OF FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2020

(₹ in Lakhs)

HYDERABAD

			Standalone			Consolidated
SI.No.		Particulars	QuarterEnded	Quarterended	QuarterEnded	QuarterEnded30.06.2020 31.03.2020 30.06.2019 30.06.2020 31.03.2020 30.06.2019	Quarterended	QuarterEnded
$\overline{1}$		Total Income from Operations (net)	11,370.73			9,955.45 11,778.85 11,370.73 9,955.45		11,778.85
$\overline{2}$		Profit from Ordinary Activities before Tax	1.381.06	863.04	1,534.11	1.381.06	863.04	1,534.11
$\overline{3}$		Profit from Ordinary Activities after Tax(after Extraordinary Items)	920.38	624.74	948.11	702.71	639.26	776.78
$\overline{4}$		Total Comprehensive Income for the quartercomprising profit/Loss) for the quarter(after tax) and other comprehensive items)	918.24	623.14	946.00	701.01	632.18	775.06
	5	Equity Share Capital(Face value of share: Re.1/- each)	846.52	846.52	846.52	846.52	846.52	846.52
	$\overline{6}$	Reserves (excluding Revaluation Reserve asper Balance Sheet) Re. 1/- each
	$\overline{7}$	Earnings per share(before extraordinary items - (Not annualized)
		a) Basic/Diluted (in Rs)	1.09	0.74	1.12	0.83	0.76	0.9
	NOTES:1 The above Standalone and consolidated Financial Results have been reviewed and recommendeby the Audit Committee and approved by the Board of Directors in their meetings held on 12tAugust, 2020 and Statutory Auditors of the Company have carried out a Limited Review.2 These results have been prepared in accordance with the Companies (Indian AccountinStandards) Rules, 2015 (Ind AS) prescribed Under Section 133 of the Companies Act, 2013 another recognized accounting practices and policies to the extent applicable.The above is an extract of detailed format of quarterly / annual financial results filed with the3stock exchanges under regulation 33 of the SEBI (LODR) Regulations, 2015. The full formatquarterly / annual financial results are available on the website of the Stock Exchanges of BSwww.bseindia.com(ID 532815) or NSE (www.nseindia.com) and companies websitBy order of the Board(www.SMSPHARMA.com).for SMS PHARMACEUTICALS LIMITEDRAMESH BABU POTLURI(DIN:00166381)Place: Hyderabad
	Chairman and Managing DirectorDate: 12-08-2020

Place: Hyderabad Date: 12-08-2020